| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/2014 | US20140010821 Use of CD83 in combination therapies |
| 01/09/2014 | US20140010809 Binding domain-immunoglobulin fusion proteins |
| 01/09/2014 | US20140010801 Compositions and Methods for Restoring or Rejuvenating Stem/Progenitor Cell Function |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010791 Methods for regulating protein function in cells in vivo using synthetic small molecules |
| 01/09/2014 | US20140010789 Compositions and methods for modulating emt and uses thereof |
| 01/09/2014 | US20140010788 Administration of Enzyme and Prebiotic Combinations that Enhance Probiotic Growth and Efficacy |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | US20140010783 Antiviral compounds |
| 01/09/2014 | US20140010782 Antibacterial agent for treating infectious diseases of bacterial origin |
| 01/09/2014 | US20140010781 Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancer |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010777 Methods for determining personalized treatment compositions for prostate cancer and breast cancer |
| 01/09/2014 | US20140010756 Composition for treatment and diagnosis of pancreatic cancer |
| 01/09/2014 | US20140007873 Dry powder inhaler and system for drug delivery |
| 01/09/2014 | CA2878322A1 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | CA2878292A1 Potentiation of antibiotic treatment with a protein-lipid complex |
| 01/09/2014 | CA2878100A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | CA2877872A1 Methods for determining personalized treatment compositions for prostate cancer and breast cancer |
| 01/09/2014 | CA2877745A1 Treatment of inflammatory skin disorders |
| 01/09/2014 | CA2877441A1 Complement split product c4d for the treatment of inflammatory conditions |
| 01/09/2014 | CA2877056A1 Use of long-acting glp-1 peptides |
| 01/08/2014 | EP2682463A1 Bacteriocin derived from lactobacillus rhamnosus |
| 01/08/2014 | EP2682407A1 Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier, each containing same |
| 01/08/2014 | EP2682406A2 Fusion protein comprising albumin and a retinol-binding protein |
| 01/08/2014 | EP2682128A1 Medicinal agent for inhibiting metastasis of malignant tumor |
| 01/08/2014 | EP2682126A1 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 01/08/2014 | EP2682125A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 200 units |
| 01/08/2014 | EP2682124A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 01/08/2014 | EP2681559A1 Peptide-lipid constructs and their use in a fc-function assay |
| 01/08/2014 | EP2681316A1 Isolated laminin-421 |
| 01/08/2014 | EP2681280A1 Biomaterial, method for making the biomaterial and uses of the same |
| 01/08/2014 | EP2681235A1 Hydrogen bond surrogate macrocycles as modulators of ras |
| 01/08/2014 | EP2680879A2 Peptide linkers for polypeptide compositions and methods for using same |
| 01/08/2014 | EP2680878A1 Treatment for ige-mediated disease |
| 01/08/2014 | EP2680877A2 Coupling endonucleases with end-processing enzymes drive high efficiency gene disruption |
| 01/08/2014 | EP2680876A1 Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor |
| 01/08/2014 | EP2680875A1 Coagulation factor-targeting to tlt-1 on activated platelets |
| 01/08/2014 | EP2680874A2 Edn3-like peptides and uses thereof |
| 01/08/2014 | EP2680873A2 Antifungal agents and uses thereof |
| 01/08/2014 | EP2680872A2 Compositions and methods for treatment of intracellular damage |
| 01/08/2014 | EP2680871A2 Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | EP2680861A1 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| 01/08/2014 | EP2680827A1 Particles containing a growth factor, and uses thereof |
| 01/08/2014 | EP2680823A1 Binder powders |
| 01/08/2014 | EP2680822A1 Vesicle compositions |
| 01/08/2014 | EP2680713A1 Composition for nutrition purposes |
| 01/08/2014 | CN1826354B Methods for preventing and treating alzheimer's disease (AD) |
| 01/08/2014 | CN103502515A Antigen surrogates in autoimmune disease |
| 01/08/2014 | CN103502215A Prodrugs of D-gamma-glutamyl-D-tryptophan and D-gamma- glutamyl-L-tryptophan |
| 01/08/2014 | CN103502214A Prodrugs of D-isoglutamyl-[D/L]-tryptophan |
| 01/08/2014 | CN103501823A Multicomponent compositions and their uses |
| 01/08/2014 | CN103501809A Vaccines and compositions against streptococcus pneumoniae |
| 01/08/2014 | CN103501805A Compositions and mehthods for modulating gamma-c-cytokine activity |
| 01/08/2014 | CN103501804A Tear substitutes |
| 01/08/2014 | CN103501803A Therapeutic applications of smad7 |
| 01/08/2014 | CN103501802A Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same |
| 01/08/2014 | CN103501801A Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | CN103501800A Beautiful-skin-promoting agent and use thereof |
| 01/08/2014 | CN103501799A WNT compositions and methods of use thereof |
| 01/08/2014 | CN103501763A Ophthalmic preparations based on PACAP (Pituitary Adenylate Cyclase Activating Polypeptide) which restore the normal visual function in early glaucoma |
| 01/08/2014 | CN103497247A Conjugated factor VIII molecules |
| 01/08/2014 | CN103497246A Conjugated factor VIII molecules |
| 01/08/2014 | CN103497243A High-mobility fish group protein and application thereof |
| 01/08/2014 | CN103497241A Prawn anti-viral Argonaute protein, as well as encoding cDNA (complementary deoxyribonucleic acid) and application thereof |
| 01/08/2014 | CN103497240A Preparation method of a silk fibroin peptide powder hemostatic material |
| 01/08/2014 | CN103497236A Specific heptapeptide targeting to WISP-1 protein and application thereof |
| 01/08/2014 | CN103497232A Boronate ester compounds and pharmaceutical compositions thereof |
| 01/08/2014 | CN103497210A Boronate ester compounds and pharmaceutical compositions thereof |
| 01/08/2014 | CN103495182A Newcastle disease diad vaccine and preparation method thereof |
| 01/08/2014 | CN103495174A Multi-effect external preparation used for treating superficial skin injury and application thereof |
| 01/08/2014 | CN103495165A Method of administering anti-TNFalpha antibodies |
| 01/08/2014 | CN103495156A Recombinant human insulin sustained-release tablet and preparation method thereof |
| 01/08/2014 | CN103495155A Film for hyperplastic scar repair and preparation method thereof |
| 01/08/2014 | CN103495154A Antagonists of kisspeptin and uses thereof |
| 01/08/2014 | CN103495153A Method for detecting mutations in a gene associated with resistance to viral infection, OAS1 |
| 01/08/2014 | CN103495152A Thymopentin-containing medicine composition, as well as preparation and preparation method thereof |
| 01/08/2014 | CN103495151A Traditional Chinese medicine composition for treating pig cold diarrhea and preparation method thereof |
| 01/08/2014 | CN103494769A Compound in-situ gel long-acting injection for treating chronic hepatitis and preparation method thereof |
| 01/08/2014 | CN103494052A Polypeptide infant calcium supplement instant granule and its preparation method |
| 01/08/2014 | CN103493969A Method for producing giant salamander polypeptide powder |
| 01/08/2014 | CN102908631B Function of actin 84 lysine monomethylation in cytokinesis and cell proliferation as well as application thereof to drug development |
| 01/08/2014 | CN102796167B (S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-L-prolyl-L-alanyl-L-amino acid, and preparation method and application thereof |
| 01/08/2014 | CN102660523B Low-immunogenicity lumbrukinase, preparation method and application thereof |
| 01/08/2014 | CN102586437B Application of CCDC72 gene and expression product thereof in preparing preparation for diagnosing and treating ovarian cancer |
| 01/08/2014 | CN102477081B Application of novel polypeptide in diagnosis of sjogren's syndrome |
| 01/08/2014 | CN102406922B Compound long-acting norfloxacin nicotinate suspension for livestock and preparation method thereof |
| 01/08/2014 | CN102369281B HLA-A24-binding cancer antigen peptide derived from SOX2 |
| 01/08/2014 | CN102321584B Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 01/08/2014 | CN102264429B Microneedle device |
| 01/08/2014 | CN102256614B Synthetic mimetics of host defense and uses thereof |
| 01/08/2014 | CN102199608B Efficient expression of pinellia ternate agglutinin (PTA) in bombyx mori reactor |
| 01/08/2014 | CN101678088B Modified mutant collagenase and application thereof in fat melting and in scar reduction |
| 01/08/2014 | CN101484467B Method for synthesizing thymosins |
| 01/08/2014 | CN101484180B Cxcl13 antagonists and application thereof for the treatment of inflammatory diseases |
| 01/07/2014 | US8624019 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 01/07/2014 | US8624013 Interleukin-10 antibodies |
| 01/07/2014 | US8624004 Purification of HBV antigens for use in vaccines |
| 01/07/2014 | US8624000 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |